ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
79 hedge funds and large institutions have $62.1M invested in Adamas Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 19 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 18
Holders
79
Holding in Top 10
1
Calls
$1.41M
Puts
$449K
Top Buyers
| 1 | +$6.29M | |
| 2 | +$5.65M | |
| 3 | +$1.03M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$919K |
| 5 |
Renaissance Technologies
New York
|
+$641K |
Top Sellers
| 1 | -$2.85M | |
| 2 | -$1.82M | |
| 3 | -$1.17M | |
| 4 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
-$1.02M |
| 5 |
DAM
Deltec Asset Management
New York
|
-$668K |